chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer and described the occurrence of feeling sick in a 42-year-old female subject who was vaccinated with FLUARIX, (GlaxoSmithKline).  A physician or other health care professional has not verified this report.  The subject's medical history included womb removed and splenectomy.  On 15 October 2007 between 10:00 and 11:10, the subject received 1st dose of Flu shot (unknown, left arm).  On 15 October 2007 between 12:00 and 13:00, within 1 hour after vaccination with Flu shot, the subject experienced feeling sick.  On 15 October 2007, less than one day after vaccination with Flu shot, the subject experienced anxiety, left leg pain, tingling (left leg) and muscle pain.  The subject reported side effects that she had experienced since having the flu shot (GSK brand unknown) on 15 October 2007.  At the time of reporting the events were unresolved.
Information has been received from a mother concerning her 8 year old daughter with no medical history who, at 12 months of age, was vaccinated SC with a 0.5ml dose of varicella virus vaccine live. There was no concomitant therapy. The patient's mother reported that her daughter subsequently developed a mild case of breakthrough varicella characterized by 19 lesions. Unspecified medical attention was sought, but no laboratory/diagnostic tests were performed. Subsequently, the patient recovered. Additional information has been requested.
HAND JERKING IN RIGHT HAND; BLURRED VISION; NUMBNESS IN RIGHT ARM; TINGLING IN RIGHT ARM; EXHAUSTION AND FATIGUE; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068, and batch number: 1802068 expiry: UNKNOWN) dose was not reported, administered on 05-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 06-MAR-2021 18:30, the subject experienced hand jerking in right hand. On 06-MAR-2021 18:30, the subject experienced blurred vision. On 06-MAR-2021 18:30, the subject experienced numbness in right arm. On 06-MAR-2021 18:30, the subject experienced tingling in right arm. On 06-MAR-2021 18:30, the subject experienced exhaustion and fatigue. On 06-MAR-2021 18:30, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from exhaustion and fatigue, and headache on 08-MAR-2021, was recovering from hand jerking in right hand, and had not recovered from blurred vision, numbness in right arm, and tingling in right arm. This report was non-serious.; Sender's Comments: V0 Medical assessment comment not required as per standard operating procedure as the case assessed as non-serious.
it was the shot/fellt like I had Shingles on my fore arm/ suspected vaccination failure; had a reaction/fellt like I had Shingles on my fore arm; ulnar nerve entrapment; Numbness/ my pinky and fourth finger that goes up my left forearm to my elbow; tingling/ my pinky and fourth finger that goes up my left forearm to my elbow; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In November 2020, unknown after receiving Shingles vaccine, the patient experienced trapped nerve, numbness in fingers and tingling. On an unknown date, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved and the outcome of the trapped nerve, numbness in fingers and tingling were recovering/resolving.   It was unknown if the reporter considered the vaccination failure, shingles, trapped nerve, numbness in fingers and tingling to be related to Shingles vaccine.  Additional details were reported as follows: The case reported by the patient. The age at vaccination was not reported. The patient might have a reaction, not sure 100 percent if it was the shingles shot, how it was administered or a combination of factor but the patient felt like he/she had shingles on his/her fore arm for weeks. Since then (November 2020), the patient had ulnar nerve entrapment or something similar, numbness and tingling in his/her pinky and fourth finger that goes up his/her left fore arm to elbow. It was better than it was but still an issue. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting. The follow up would not be possible as no contact details were available.
Sore arm next day. 6 days later : extreme dizziness, nausea, vomiting, fatigue, severe confusion
Patient reported feeling weak and ill to MA after administration of vaccines.  MA offered water and warm washcloth.  Patient felt worse, her eyes drooped. MA yelled for help, PCP in room to assess, vital signs obtained.    Vital signs: BP 61/37, P 55  Notified Emergency Response team on campus. Oxygen administered, 2L.. MD stated patient had vasovagal reaction, was not allergic reaction, requested MA to let patient sit for 15-20 minutes, then walk her around the clinic. MD advised if patient does not report any dizziness or headache, patient will be fine to go. Discharged home.
Moderna COVID-19 Vaccine EUA while driving back to work, the left side of my face felt numb.  The perfect way to describe it: after you have been to the dentist, and the novicane shots starts to wear off.  The tingling/almost pins and needles. feels kinda warm. I had this sensation all day.  I woke up the next morning and felt fine, until I had a cup of coffee, and it came back.  It lasted like this until about noon on the second day.  Now that sensation (tingling) is gone, but my left cheek/face feel tender.  (Like a dentist was stretching my cheek a day ago, while doing work on a tooth).
has daily pain in her hands; having a flare up of psoriasis; This is a spontaneous report based on information received by Pfizer from Novartis (mfr control no. NVSC2021US103908) a contactable consumer reported. A 55-years-old female patient received bnt162b2 (BNT162B2 Solution for injection), via an unspecified route of administration on an unspecified date as UNKNOWN, SINGLE for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced has daily pain in her hands and having a flare up of psoriasis on an unspecified date.  Patient stated having a flare up of psoriasis after taking the COVID vaccine also has daily pain in her hands. The outcome of the events was unknown.  Follow-up needed. Information about batch/lot number has been requested.
I received my second dose of my vaccine and within 24 hours after it, I had a frightening neurological problem. I had tunnel vision and couldn't speak like I was experiencing a stroke. I had cluster headaches that lasted for about two weeks. My neurologist gave me a course of steroids to help clear the cluster headaches. I had telehealth appointments with my neurologist and physician; they completed an MRI to ensure I wasn't having a stroke or anything at the time. Since, I've been monitored to see my progression post-vaccination.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown ages and gender. On an unknown date, the patients were vaccinated with GARDASIL (dose, route and lot number were not reported), vaccine had been exposed to multiple excursions with highest temperature reaching 57F for total time of 206 hours and these vaccines' stability could not be supported. No adverse effects reported. This is one of several reports from the same source. Follow up was linked to 1405USA001161, 1405USA001164, 1405USA001163, 1405USA001162, 1405USA001166 and 1403USA007265. Additional information has been requested.
Patient has known allergies. Patient had adverse reaction last time to vaccine. Patient advised by PCP to get second dose and take Benadryl prior to arriving. Patient tool 3 Benadryl tablets PO prior to arriving.  Patient endorses itchiness after vaccine and dizziness. Vaccine (second dose)  administered in EMS room and patient was supine. Observed for 30 minutes.
Pain at injection site x 3 wks. Presented to clinic with partially frozen shoulder. Referred for physical therapy.
Child was 2 years 8 months, and received the FLUARIX QUAD vaccination at a flu vax clinic, it is only licensed for 3 years and older. Parent was contacted 10-20-17, no adverse effects. Childs pediatrician was also notified.
04/01/2021 Arm swelling, could hardly move arm, slight feverish. Felt bad for about 24 hours, cold like symptoms. Pain in arm lasted for about 2 weeks. 04/29/2021 A little bit of swelling, a little under the weather for about 4 days.
numbness and tingling that began about 7 hours ago. She describes it as a "pins and needles" feeling in her hands with numbness in her face and intermittent left sided lip twitching. She denies any numbness or tingling in BLE. She reports having a significant headache since receiving the first dose of the COVID-19 vaccine 9 days ago and some muscle aches. She also reports some dizziness which she describes as lightheadedness, but denies any LOC
The young man came to the vaccine clinic because his guardian wanted him to recieve the covid vaccine. Staff asked the young man what he was receiving today and he replied the flu and the covid vaccine. Staff administed the flu vaccine to his right deltoid, and the Covid bivalent booster to his left arm. The patient returned to class after waiting 15 mintues. Staff went to speak to the  nurse about returning the following day with the original covid vaccine for some siblings who recently recieved the first dose. At this time, we found out that the young man was also their sibling, and was supposed to be recieving the original vaccine as well. Staff went to notify the nurse so she could speak with the guardian. Staff then contacted the HCF to nofity the director and doctor about the vaccine incident. The nurse reported that the pt. had not expereinced any side effects from the vaccine since administration. The doctor advised to administed the original covid vaccine series to the pt. so he can be proberly protected. The first dose of the covid series was administered to the boy on 12/6/2022.
Information has been received from a nurse practitioner concerning a 24 year old female with KEFLEX allergy and irregular heartbeat who on 30-MAR-2009 was intramuscularly vaccinated with the first 0.5 ml dose of GARDASIL (lot # 659182/1757U). On 06-APR-2009 the patient experienced facial flushing, intermittent nausea, intermittent headache and continued exhaustion. At the time of reporting, the patient did not recover. Follow-up information was received from the nurse practitioner who reported the patient had received the first dose of GARDASIL. The reporter stated that she had spoken with the patient over the phone on 21-APR-2009. The patient stated that she had fully recovered. Additional information has been requested.
Extreme exhaustion within 3 hours, lasting 3 full days, unable to get out of bed and mostly slept the full time; piercing headache and extremely dizzy began within 17 hours and lasted 2 full days. Hot sweats off and on, continuing for 1 week and counting.
A non-serious, spontaneous report of chest pain, runny nose, sniffles and cough has been received from a registered nurse concerning an eight-year-old patient after receiving FLUMIST. Medical history included seasonal allergies and bronchial pneumonia. Concomitant medications included oral cetirizine 2.5 mg as needed and oral diphenhydramine 12.5 mg as needed. On 04-Sep-2009, the patient received a single dose of FLUMIST. On 06-Sep-2009, the patient developed a runny nose, sniffles and cough. On 07-Sep-2009, all of the events resolved. On 08-Sep-2009, the school nurse called the patient's mother and reported that the child had chest pains while on the playground. The patient had some water and then rested. The pain improved. On 10-Sep-2009, the patient went to the pediatrician and was diagnosed with allergies not related to FLUMIST. He was prescribed oral montelukast sodium 5 mg once a day. The outcome of the events, runny nose, sniffles and cough, was resolved on 07-Sep-2009. The outcome of the event, chest pains, was not recovered/not resolved. The pediatrician assess the events, chest pain, runny nose, sniffles and cough, as not related to FLUMIST. He attributed these events of allergies.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021 at 11:58 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 13-Feb-2021 at 11:58 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was reported as 23.84.  Concomitant products were not reported.  On 13-Feb-2021, Excursion time was 09 AM, temperature was 32, total doses given for the day was 152, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 9-Feb-2021, vial was moved to clinic on 13-Jan-2021. 30 vials were sent to clinic. Vaccine BUD date was 10-Mar-2021. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Mother returned with pt stating that pt had been crying for about 30 min she thought that he was hunger and tryed to nurse him but he would not feed he had worked up a sweat so she removed his pants and saw that his leg were the inj had been placed was red so she came back to the office. Pt was given tylenol and benadryl the redness went away and pt fell a sleep.
productive cough, nonproductive cough,, nasal congestion, sneezing, itchy eyes. starting 1/10/22
pt noted immediate onset of pain and weakness in R shoulder on 11/10/2020, exacerbated by raising arm. Pain radiated to R arm with corresponding paresthesia of R 3rd, 4th and 5th fingers. Presented to clinic 3 weeks after immunization  12/1/2020 with report of symptoms. Was treated with prednisone taper, which resolved discomfort until the dose began to be tapered down, is also taking Tylenol. (pt unable to take ibuprofen due to reported interaction with her psych meds). presented again today 12/16/2020 via telemed with reported resumption of pain after d/c of the prednisone and continued pain, weakness and paresthesia
administered infanrix/ Date of birth Mar 13th 2008; administered infanrix/ Boostrix was the vaccine indicated; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 13-year-old male patient who received DTPa (Infanrix) (batch number 7EC55, expiry date 29th April 2023) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 15th September 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 15th September 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: A health care professional administered infanrix to a patient of age 13 years old, instead Boostrix was the vaccine indicated for the patient, which led to inappropriate age at vaccine administration and wrong vaccine administered. The reporter consented to follow up. This case was 1 of 7 linked cases reported by same reporter for different patients.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021201378:same reporter US-GLAXOSMITHKLINE-US2021201377:same reporter US-GLAXOSMITHKLINE-US2021201373:same reporter US-GLAXOSMITHKLINE-US2021201375:same reporter US-GLAXOSMITHKLINE-US2021201376:same reporter US-GLAXOSMITHKLINE-US2021201380:same reporter
Vaxelis and Hiberix given on same day; Hiberix given by mistake instead of PCV vaccine; This case was reported by a physician via call center representative and described the occurrence of accidental overdose in a 2-year-old male patient who received Hib (Hiberix) (batch number EK5Y2, expiry date 25th May 2023) for prophylaxis.   Co-suspect products included VAXELIS for prophylaxis.   On 8th February 2023, the patient received Hiberix and VAXELIS. On 8th February 2023, unknown after receiving Hiberix, the patient experienced accidental overdose and wrong vaccine administered. On an unknown date, the outcome of the accidental overdose and wrong vaccine administered were unknown.   Additional Information: GSK Receipt Date: 16-FEB-2023 Reporter's Comment:  The reporter reported that the patient was almost 3 years old and received Vaxelis and Hiberix vaccine. The reporter stated that the patient was supposed to receive Vaxelis and PCV vaccine but received Hiberix vaccine by mistake.  The vaccine administration facility was the same as primary reporter. The reporter did consent to follow up. Additional supportive information: The reporter reported that, they were intending to administered PCV vaccine and inadvertently administered Hiberix instead of PCV vaccine, which led to wrong vaccine administered. The patient received Vaxelis and Hiberix vaccine on same day, which led to accidental overdose.
c/o CP during 15 minute monitoring period. No SOB. No airway involvement.
First 24 hours: fever, body chills, muscle weakness and sore First 48 hours: entire face broke out in acne and rash across cheeks, jaw, and neck
A burning sensation to both anterior portion of my feet started on 1/11/21. On 2/3/21, the burning became severe with swelling to both feet. The burning extended to my ankles and then up to mid calf. The symptoms continue today. Contact PCP who ordered US of lower extremities and referral to vascular MD. Visited Vascular MD who ordered additional US and then performed a Vascular Ablation bilaterally hoping to help with pain. vascular MD was not convinced a 100% the burning was from veins because US didn't give a severity to indicate such burning. At the same time working with pain management MD because of history of CRPS to the right side of my body. Thought maybe the burning could be CRPS/ veins.
After first shot, a painful lump swelling occurred above the calf of left leg; breast swelling and tenderness in left breast.  After second vaccination, pain in both hips, left knee and right elbow limiting activity and causing disruption of sleep due to the pain.  Vision in left eye is altered
Flu shot. Chills and severe muscle aches during night. Slept for hours after. Still tired after two days.
Guest was given vaccination lying down due to headache, nausea with last vaccination.  Elevated blood pressure with headache and nausea, blood pressure was high before vaccination (179/102) but guest still wanted to proceed with vaccination.  After vaccination guest c/o dizziness, headache and nausea.  BP 168/99, spo2 100%, pulse 90.  Guest wanted to go to ER after 15 minutes under observation.
Moderate/severe pain at injection site. More fatigued than normal. Tightness in jaw (bilateral) with secondary pain in bilateral ear, neck pain.
This case was reported by a nurse via call center representative and described the occurrence of diarrhea in an unspecified number of adult patients who received SHINGRIX for prophylaxis. On an unknown date, the patients received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patients experienced diarrhea, nausea and abdominal pain. On an unknown date, the outcome of the diarrhea, nausea and abdominal pain were unknown. It was unknown if the reporter considered the diarrhea, nausea and abdominal pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not applicable. Age group was not reported but was captured as adult as per vaccine indication. The nurse stated that they had a lot of patients who experienced gastrointestinal symptoms such as diarrhea, nausea and abdominal pain after vaccination with SHINGRIX. The reporter had not consent to follow up.
I received the Pfizer booster vaccine at approximately 4:30PM on Sunday, November 14th. I awoke with a sore arm Monday, November 15th and Tuesday, November 16th. It was not until Wednesday, November 17th I began to feel dizzy and nauseas. By Friday, November 19th I was experiencing  dizziness, chills, exhaustion/fatigue, muscle weakness, trouble sleeping, and diarrhea. By Sunday, November 21st, I noticed a fever of 100 and was still experiencing all of the previous symptoms listed as well as vomiting. Today, Monday, November 22nd, I still feel the previous symptoms. I have let my PCP know of this experience and I will likely have to be seen and have further intervention tomorrow unless I miraculously feel better.
Chills; fever; muscle soreness; injection site red/inflamed/sensitive to touch; headache; temperature of 103; Trip to ER July 27 approximately 9:00pm. Diagnosis: Injection site infection along with UTI.
25FEB93 pt reported welts all over since immun on 16FEB93; pt began on 17FEB on meds for; 2MAR93 form completed w/help of the mom; reports a fever unk temp; stated bruising only @ site;
On 06/09/2000 the patient experienced red, raised nickel sized bumps at the injection site. No further information is available.
Left deltoid became swollen and red, for a few days, now improving but still slightly red and yellow.  According to pt, looked similar to cellulitis.
PT reported swelling/fluid retention at site/soreness and tightness in upper arm and back of neck in addition to fever. PT WAS ALSO ADMINISTERED PNEUMOVAX in the same arm (RIGHT).